Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. (DAWN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DAWN · as of Jun 8, 2026
Key Statistics
Explore Day One Biopharmaceuticals, Inc. Data
dawn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 50.0%
The DAWN analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $21.50, representing -0.14% downside from the current price of $21.53.
Competitors & Peers
dawn competitorsDAWN
ARVN
ATXS
AVBP
ERAS
GERNStock Performance
Full HistoryAbout Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate i…
what is day one biopharmaceuticals, inc. · dawn stock overview · day one biopharmaceuticals, inc. company profile · who is day one biopharmaceuticals, inc. ceo · dawn NASDAQ · day one biopharmaceuticals, inc. headquarters · day one biopharmaceuticals, inc. business segments
About Stock Overview & Key Data
Day One Biopharmaceuticals, Inc. (DAWN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 27, 2021. As of the latest trading session, DAWN stock price is $21.53, with a market capitalization of $2.2B. The stock has returned +241.75% over the past 12 months and +131.01% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Day One Biopharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $21.50. In fiscal year 2025, Day One Biopharmaceuticals, Inc. reported revenue of $158.2M and net income of -$107.3M. For detailed data — including Day One Biopharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Day One Biopharmaceuticals, Inc. (DAWN) stock price is $21.53. The stock is traded on NASDAQ under the ticker symbol DAWN. The 52-week range is $5.63 – $21.53.